The 23andMe Research Institute bought the company's assets for $305 million, scotching a proposed sale to Regeneron ...
As directors push for technology transformation, a new survey reveals a striking confidence gap in risk oversight—especially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback